Effect of metoprolol on heart rate
Pro Research Analysisby 
Searched over 200M research papers
Effect of Metoprolol on Heart Rate
Introduction to Metoprolol and Heart Rate Control
Metoprolol, a beta-blocker, is widely used to manage various cardiovascular conditions by reducing heart rate and myocardial oxygen demand. This article synthesizes findings from multiple studies to elucidate the effects of metoprolol on heart rate in different patient populations.
Metoprolol in Acute Myocardial Infarction
Hemodynamic Effects in Low Heart Rate Patients
In patients with acute myocardial infarction (AMI) and a heart rate of ≤65 beats per minute (bpm), metoprolol significantly reduced heart rate, cardiac index, rate pressure product, and stroke work index by 10-20% compared to placebo. These effects were most pronounced immediately after administration . Another study confirmed these findings, showing a 10-20% reduction in heart rate and other hemodynamic parameters in AMI patients with heart rates >65 bpm .
Dose-Related Effects in Heart Failure
Immediate-Release vs. Controlled-Release Metoprolol
In chronic heart failure patients, metoprolol's effect on heart rate was dose-dependent. Immediate-release (IR) metoprolol 50 mg three times daily produced similar peak plasma levels to controlled-release/extended-release (CR/XL) metoprolol 200 mg once daily. However, CR/XL 200 mg resulted in a more pronounced heart rate reduction compared to IR 50 mg .
Chronic Stable Angina and Ischemia
Reduction in Ischemic Episodes
In patients with chronic stable angina, metoprolol significantly reduced the frequency and duration of ischemic episodes and the heart rate at the onset of ischemia. This reduction in heart rate indicates a decrease in myocardial oxygen demand during ischemic episodes . Additionally, metoprolol reduced the frequency and total time of silent ischemic episodes, with a notable decrease in mean daily heart rate and heart rate at the onset of ischemia .
Sex-Based Differences in Heart Rate Reduction
Higher Risk of Bradycardia in Women
A population-based study revealed that women had a stronger heart rate reduction and a higher risk of bradycardia at higher metoprolol plasma concentrations compared to men. Women in the highest concentration group had a significantly higher risk of bradycardia than those in the lowest concentration group .
Impact on Cardiac Function in Dilated Cardiomyopathy
Rest and Exercise Heart Rate
In patients with idiopathic dilated cardiomyopathy (IDCM), metoprolol treatment significantly decreased heart rate both at rest and during exercise. This reduction was associated with improved left ventricular ejection fraction and diastolic function . Similarly, in chronic heart failure patients, metoprolol reduced resting and peak exercise heart rates, improving overall cardiac performance and aerobic capacity .
Genetic Polymorphisms and Heart Rate Response
CYP2D6 Polymorphism
Patients with poor CYP2D6 metabolism exhibited a greater reduction in heart rate and blood pressure during metoprolol treatment compared to those with active CYP2D6 phenotypes. Poor metabolizers also had a higher risk of bradycardia, suggesting the need for personalized dosing based on genetic profiling .
Conclusion
Metoprolol effectively reduces heart rate across various cardiovascular conditions, including acute myocardial infarction, chronic heart failure, and stable angina. The degree of heart rate reduction is influenced by dosage, formulation, sex, and genetic factors. These findings underscore the importance of personalized treatment strategies to optimize therapeutic outcomes and minimize adverse effects.
Sources and full results
Most relevant research papers on this topic